BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 26432560)

  • 1. A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation.
    Vasu S; Berg M; Davidson-Moncada J; Tian X; Cullis H; Childs RW
    Cytotherapy; 2015 Nov; 17(11):1582-93. PubMed ID: 26432560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
    Boissel L; Tuncer HH; Betancur M; Wolfberg A; Klingemann H
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo expansion of natural killer cells using cryopreserved irradiated feeder cells.
    Baek HJ; Kim JS; Yoon M; Lee JJ; Shin MG; Ryang DW; Kook H; Kim SK; Cho D
    Anticancer Res; 2013 May; 33(5):2011-9. PubMed ID: 23645750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.
    Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U
    Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.
    Spanholtz J; Tordoir M; Eissens D; Preijers F; van der Meer A; Joosten I; Schaap N; de Witte TM; Dolstra H
    PLoS One; 2010 Feb; 5(2):e9221. PubMed ID: 20169160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood.
    Condiotti R; Zakai YB; Barak V; Nagler A
    Exp Hematol; 2001 Jan; 29(1):104-13. PubMed ID: 11164111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7. Potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation.
    Robinson KL; Ayello J; Hughes R; van de Ven C; Issitt L; Kurtzberg J; Cairo MS
    Exp Hematol; 2002 Mar; 30(3):245-51. PubMed ID: 11882362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering.
    Ayello J; van de Ven C; Fortino W; Wade-Harris C; Satwani P; Baxi L; Simpson LL; Sanger W; Pickering D; Kurtzberg J; Cairo MS
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):608-22. PubMed ID: 16737934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
    Lin SJ; Kuo ML
    Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic function of umbilical cord blood natural killer cells: relevance to adoptive immunotherapy.
    Lin SJ; Kuo ML
    Pediatr Hematol Oncol; 2011 Nov; 28(8):640-6. PubMed ID: 21970456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel myeloid-like NK cell progenitor in human umbilical cord blood.
    Perez SA; Sotiropoulou PA; Gkika DG; Mahaira LG; Niarchos DK; Gritzapis AD; Kavalakis YG; Antsaklis AI; Baxevanis CN; Papamichail M
    Blood; 2003 May; 101(9):3444-50. PubMed ID: 12506032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple method for in vitro preparation of natural killer cells from cord blood.
    Mu YX; Zhao YX; Li BY; Bao HJ; Jiang H; Qi XL; Bai LY; Wang YH; Ma ZJ; Wu XY
    BMC Biotechnol; 2019 Nov; 19(1):80. PubMed ID: 31752805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process.
    Spanholtz J; Preijers F; Tordoir M; Trilsbeek C; Paardekooper J; de Witte T; Schaap N; Dolstra H
    PLoS One; 2011; 6(6):e20740. PubMed ID: 21698239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo expansion of T, NK and CD34+ cells from umbilical cord blood.
    Wei YM; Cao Q; Zhou HY; Xia R; Lan JC; Meng FY; Bai H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1076-81. PubMed ID: 16403284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryopreservation has no effect on function of natural killer cells differentiated in vitro from umbilical cord blood CD34(+) cells.
    Domogala A; Madrigal JA; Saudemont A
    Cytotherapy; 2016 Jun; 18(6):754-9. PubMed ID: 27090754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cells.
    Harada H; Watanabe S; Saijo K; Ishiwata I; Ohno T
    Exp Hematol; 2004 Jul; 32(7):614-21. PubMed ID: 15246157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells.
    Carlens S; Gilljam M; Chambers BJ; Aschan J; Guven H; Ljunggren HG; Christensson B; Dilber MS
    Hum Immunol; 2001 Oct; 62(10):1092-8. PubMed ID: 11600215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity.
    Shah N; Martin-Antonio B; Yang H; Ku S; Lee DA; Cooper LJ; Decker WK; Li S; Robinson SN; Sekine T; Parmar S; Gribben J; Wang M; Rezvani K; Yvon E; Najjar A; Burks J; Kaur I; Champlin RE; Bollard CM; Shpall EJ
    PLoS One; 2013; 8(10):e76781. PubMed ID: 24204673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo expansion of CD3
    Hosseini E; Ghasemzadeh M; Kamalizad M; Schwarer AP
    Stem Cell Res; 2017 Mar; 19():148-155. PubMed ID: 28171825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.